Incomplete Recovery of Erectile Function in Rats After Discontinuation of Dual 5-Alpha Reductase Inhibitor Therapy

July 2012 in “ The Journal of Sexual Medicine ”

Çetin Volkan Öztekin, Serap Gür, Nour A. Abdulkadir, Utku Lokman, Alp Özgür Akdemir, Mesut Çetinkaya, Wayne J.G. Hellstrom

5-alpha reductase inhibitor dutasteride intracavernosal pressure mean arterial pressure 5ARI

Studysummary In this study using a rat model, discontinuing dutasteride improved some relaxant responses but did not fully restore erectile function, indicating a potential time-dependent detriment of the drug.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The study investigated the long-term effects of the 5-alpha reductase inhibitor (5ARI) dutasteride on erectile function in rats. Twenty-six adult male Sprague-Dawley rats were divided into three groups: a control group (N = 10), an 8-week dutasteride treatment group (N = 8), and a 6-week dutasteride treatment followed by a 2-week washout period group (N = 8). The results showed that erectile function, as measured by intracavernosal pressure (ICP) to mean arterial pressure (MAP) ratio and total ICP, was significantly decreased in the treatment groups compared to controls. Although some erectile responses improved after discontinuation of dutasteride, not all functions recovered, indicating a potentially lasting negative impact on erectile function. The study concluded that the withdrawal effects of 5ARIs on human sexual function warrant further investigation.

View this study on sciencedirect.com →

Discuss this study in the Community →

Research cited in this study

6 / 6 results

research Role of 5α-Reductase Inhibitors in Benign Prostatic Diseases

24 citations , February 2012 in “Prostate cancer and prostatic diseases”

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

research An Old Problem with a New Cause: 5 Alpha Reductase Inhibitors and Persistent Sexual Dysfunction

9 citations , July 2011 in “The Journal of Sexual Medicine”

This article examines 5 alpha-reductase inhibitors and their link to persistent sexual dysfunction, but it reports no new clinical findings.

research Persistent Sexual Side Effects of Finasteride for Male Pattern Hair Loss

185 citations , March 2011 in “The Journal of Sexual Medicine”

This study found that 94% of healthy men reported low libido and 92% reported erectile dysfunction as persistent sexual side effects after using finasteride for male pattern hair loss, with these effects lasting on average 40 months post-discontinuation.

Adverse Side Effects of 5α-Reductase Inhibitors Therapy: Persistent Diminished Libido, Erectile Dysfunction, and Depression in a Subset of Patients

research Adverse Side Effects of 5α-Reductase Inhibitors Therapy: Persistent Diminished Libido, Erectile Dysfunction, and Depression in a Subset of Patients

223 citations , December 2010 in “The Journal of Sexual Medicine”

This review discusses persistent adverse effects of 5α‐reductase inhibitors, like diminished libido and erectile dysfunction, in some patients and highlights the need for patient discussions before therapy, especially for androgenetic alopecia.

research 5-Alpha Reductase Inhibitors and Erectile Dysfunction: The Connection

78 citations , December 2008 in “The Journal of Sexual Medicine”

This review highlights that sexual dysfunction associated with 5-alpha-reductase inhibitors is recognized in clinical literature, with erectile dysfunction being the most common adverse effect, followed by ejaculatory dysfunction and decreased libido.

The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen, and Sexual Function in Healthy Young Men

research The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen, and Sexual Function in Healthy Young Men

72 citations , April 2008 in “The Journal of urology/The journal of urology”

This study found that 1-year use of 5alpha-reductase inhibitors, dutasteride or finasteride, significantly lowered dihydrotestosterone levels without adversely affecting bone density, lipids, or hemoglobin in normal men.